What is the treatment ICD code for Pulmonary Embolism (PE) due to a Cesarean Section (C-Section)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The ICD-10 code for pulmonary embolism (PE) due to cesarean section is O88.23 (Thromboembolism in the puerperium). This code specifically identifies a pulmonary embolism occurring during the postpartum period as a complication of cesarean delivery.

Treatment Approach

Treatment typically involves anticoagulation therapy, usually starting with low molecular weight heparin (LMWH) such as enoxaparin 1 mg/kg twice daily or 1.5 mg/kg once daily, as recommended by the 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism 1.

Key Considerations

  • LMWH is the treatment of choice for PE during pregnancy due to its predictable pharmacokinetics and favorable risk profile compared to unfractionated heparin (UFH), vitamin K antagonists (VKAs), and direct oral anticoagulants (DOACs) 1.
  • The management of labor and delivery requires careful planning, including consideration of the timing of anticoagulation and the potential risks associated with regional anesthesia 1.
  • Anticoagulant treatment should be administered for at least 6 weeks after delivery, with a minimum overall treatment duration of 3 months, and can include LMWH and warfarin, which are safe for breastfeeding mothers 1.

Supportive Care

Immediate supportive care includes oxygen therapy, pain management, and hemodynamic monitoring. For massive PE with hemodynamic instability, thrombolytic therapy may be considered, though this carries increased bleeding risks in the postpartum period 1.

Prevention of Recurrent Thromboembolism

Anticoagulation is crucial as it prevents clot propagation and allows the body's natural fibrinolytic system to dissolve existing clots, reducing the risk of recurrent thromboembolism, which can be life-threatening. The decision to extend anticoagulation should be based on the individual's risk of recurrent VTE and anticoagulant-related bleeding 1.

From the Research

Treatment for Pulmonary Embolism due to Cesarean Section

  • The treatment for pulmonary embolism (PE) due to cesarean section involves anticoagulants such as warfarin, unfractionated heparin (UFH), and low-molecular-weight heparins 2.
  • In cases of massive PE, rescue thrombolytic therapy may be used, as seen in two case reports where patients were treated with alteplase due to suspected massive pulmonary embolism after cesarean section 3.
  • Systemic thrombolysis has also been used to treat acute life-threatening PE during cesarean section, followed by post-partum rescue hysterectomy 4.
  • Surgical embolectomy may still be considered in critical cases where thrombolysis is contraindicated and mechanical disintegration with a catheter is unsuccessful 5.

ICD Code for PE due to Cesarean Section

  • Unfortunately, there is no specific information provided in the studies regarding the ICD code for PE due to cesarean section.
  • However, it is essential to note that ICD codes are used for classification and coding of diseases, symptoms, and procedures, and the specific code for PE due to cesarean section would depend on the ICD version being used.

Clinical Considerations

  • The management of PE due to cesarean section requires a multidisciplinary approach, involving obstetricians, anesthesiologists, and other healthcare professionals 4.
  • Early recognition and prompt treatment of PE are crucial to prevent serious complications and improve patient outcomes 3, 4.
  • The use of anticoagulants and thrombolytic therapy should be carefully considered, taking into account the patient's individual risk factors and medical history 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.